Niki BioSolutions Inc

Aptorum Group Ltd is a clinical-stage biopharmaceutical company based in the United Kingdom. It develops and commercialises new therapeutics and innovative treatments to address unmet medical needs, particularly in oncology and infectious diseases. Operating within the pharmaceuticals and biotechnology sector, Aptorum Group Ltd employs a diversified approach to medicine, including novel small molecules and natural product derivatives. Its work aims to address complex diseases and improve patient outcomes through scientific innovation. Add this stock to your eToro watchlist to receive news and updates on the APM share price. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.